---
$id: https://graph.org.ai/products/commodity/51171961
$type: Product
source: UNSPSC
code: "51171961"
title: "Rotraxate"
class: "51171900"
classTitle: "Antiulcer and related gastrointestinal GI drugs"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rotraxate

**UNSPSC Code**: 51171961
**Class**: [Antiulcer and related gastrointestinal GI drugs](Antiulcer and related gastrointestinal GI drugs.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-ulcer agent with the molecular formula C17H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KRN50N3Y2T, chemically known as benzenepropanoic acid, 4-((4-(aminomethyl)cyclohexyl)carbonyl)-, trans- but generally known as rotraxate, which bears US NIH Compound Identifier 65829. European Medicines Agency schedules Rotraxate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10393MIG. The term ROTRAXATE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). ROTRAXATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rotraxate under HS 29225000 and SITC 51467. As of Q4 2014, ROTRAXATE remains the US FDA Preferred Term for this commodity. Rotraxate bears US NLM identifiers UMLS ID C2699113 and NCI Concept Code C76490. SMILES: O=C(C1CCC(CC1)CN)C1CCC(CC1)CCC(=O)O.

